SE303829B - Injicerbar röntgenkontrastmedelskomposition - Google Patents
Injicerbar röntgenkontrastmedelskompositionInfo
- Publication number
- SE303829B SE303829B SE12786/64A SE1278664A SE303829B SE 303829 B SE303829 B SE 303829B SE 12786/64 A SE12786/64 A SE 12786/64A SE 1278664 A SE1278664 A SE 1278664A SE 303829 B SE303829 B SE 303829B
- Authority
- SE
- Sweden
- Prior art keywords
- acid
- calcium
- iodinated
- calcium ions
- acetamido
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000002872 contrast media Substances 0.000 title abstract 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract 5
- 229910001424 calcium ion Inorganic materials 0.000 abstract 5
- 239000002253 acid Substances 0.000 abstract 4
- -1 amine salt Chemical class 0.000 abstract 4
- 150000007513 acids Chemical class 0.000 abstract 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 2
- GLGWTRLACKFOMB-UHFFFAOYSA-N 3-acetamido-2,4,6-triiodo-5-(propanoylamino)benzoic acid Chemical compound CCC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I GLGWTRLACKFOMB-UHFFFAOYSA-N 0.000 abstract 1
- GNOGSFBXBWBTIG-UHFFFAOYSA-N Acetrizoic acid Chemical compound CC(=O)NC1=C(I)C=C(I)C(C(O)=O)=C1I GNOGSFBXBWBTIG-UHFFFAOYSA-N 0.000 abstract 1
- YBVUSFNMKKNZSQ-UHFFFAOYSA-N C(C)(=O)NC=1C(=C(C(=C(C(=O)O)C1I)I)C(=O)NC)I.C(CC)(=O)NC=1C(=C(C(=O)O)C(=C(C1I)NC(CC)=O)I)I Chemical compound C(C)(=O)NC=1C(=C(C(=C(C(=O)O)C1I)I)C(=O)NC)I.C(CC)(=O)NC=1C(=C(C(=O)O)C(=C(C1I)NC(CC)=O)I)I YBVUSFNMKKNZSQ-UHFFFAOYSA-N 0.000 abstract 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- UXIGWFXRQKWHHA-UHFFFAOYSA-N Iotalamic acid Chemical compound CNC(=O)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I UXIGWFXRQKWHHA-UHFFFAOYSA-N 0.000 abstract 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 239000002738 chelating agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001860 citric acid derivatives Chemical class 0.000 abstract 1
- 229940039231 contrast media Drugs 0.000 abstract 1
- 229960005223 diatrizoic acid Drugs 0.000 abstract 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 abstract 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 abstract 1
- 229960000929 iotalamic acid Drugs 0.000 abstract 1
- 229960004712 metrizoic acid Drugs 0.000 abstract 1
- GGGDNPWHMNJRFN-UHFFFAOYSA-N metrizoic acid Chemical compound CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I GGGDNPWHMNJRFN-UHFFFAOYSA-N 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- G—PHYSICS
- G10—MUSICAL INSTRUMENTS; ACOUSTICS
- G10L—SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
- G10L15/00—Speech recognition
- G10L15/02—Feature extraction for speech recognition; Selection of recognition unit
- G10L2015/022—Demisyllables, biphones or triphones being the recognition units
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB41842/63A GB1069437A (en) | 1963-10-23 | 1963-10-23 | Injectable x-ray contrast media |
| US34421364A | 1964-02-12 | 1964-02-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE303829B true SE303829B (sv) | 1968-09-09 |
| SE303829C SE303829C (sv) | 1972-04-17 |
Family
ID=26264759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE1278664A SE303829C (sv) | 1963-10-23 | 1964-10-23 | Injicerbar röntgenkontrastmedelskomposition |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3347746A (sv) |
| AT (1) | AT263997B (sv) |
| BE (1) | BE654702A (sv) |
| BR (1) | BR6463683D0 (sv) |
| CH (1) | CH438584A (sv) |
| DE (1) | DE1234931B (sv) |
| DK (1) | DK109526C (sv) |
| FI (1) | FI44670C (sv) |
| FR (1) | FR3758M (sv) |
| GB (1) | GB1069437A (sv) |
| IT (1) | IT1044727B (sv) |
| NL (1) | NL152753B (sv) |
| SE (1) | SE303829C (sv) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK155714B (da) * | 1978-07-04 | 1989-05-08 | Nyegaard & Co As | Fremgangsmaade til fremstilling af en steril, injicerbar, fysiologisk acceptabel oploesning af et roentgenkontrastmiddel, samt en oploesning af roentgenkontrastmidlet til brug ved fremgangsmaaden |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3855405A (en) * | 1969-11-26 | 1974-12-17 | Squibb & Sons Inc | Radiographic contrast composition containing 2{40 ,6{40 -diiodo-dl-thyronine and methods of use thereof |
| GB9020091D0 (en) * | 1990-09-14 | 1990-10-24 | Nycomed As | Contrast media |
| GB2465663A (en) * | 2008-11-26 | 2010-06-02 | Ge Healthcare As | X-ray contrast agent compositions comprising an iodinated X-ray contrast agent and ethylenediamine-N,N-disuccinic acid |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2132351A (en) * | 1934-07-14 | 1938-10-04 | Winthrop Chem Co Inc | Stable aqueous solutions of subtances having an anesthetic effect |
| US2268915A (en) * | 1939-05-27 | 1942-01-06 | Hahnemann Res Foundation | Method and material for detoxifying local anesthetics |
| US2820814A (en) * | 1955-03-21 | 1958-01-21 | Schering Corp | Polyiodinated 5-aminoisophthalic acids, salts, and esters |
| US3009952A (en) * | 1957-04-17 | 1961-11-21 | Sterling Drug Inc | Preparation of halogenated isophthalic acids |
| US2921884A (en) * | 1957-09-30 | 1960-01-19 | Sterling Drug Inc | Pharmaceutical compositions |
| US3033757A (en) * | 1959-04-08 | 1962-05-08 | Mallinckrodt Chemical Works | X-ray contrast agents |
| US3175952A (en) * | 1963-05-29 | 1965-03-30 | Sterling Drug Inc | Aqueous radiopaque solutions containing sodium and calcium ions |
-
1963
- 1963-10-23 GB GB41842/63A patent/GB1069437A/en not_active Expired
-
1964
- 1964-10-09 FI FI642131A patent/FI44670C/sv active
- 1964-10-12 DK DK502264AA patent/DK109526C/da active
- 1964-10-12 US US403356A patent/US3347746A/en not_active Expired - Lifetime
- 1964-10-15 FR FR991501A patent/FR3758M/fr not_active Expired
- 1964-10-16 CH CH1347464A patent/CH438584A/de unknown
- 1964-10-19 AT AT885264A patent/AT263997B/de active
- 1964-10-21 IT IT22488/64A patent/IT1044727B/it active
- 1964-10-22 BE BE654702D patent/BE654702A/xx unknown
- 1964-10-23 SE SE1278664A patent/SE303829C/sv unknown
- 1964-10-23 NL NL646412391A patent/NL152753B/xx not_active IP Right Cessation
- 1964-10-23 DE DEN25719A patent/DE1234931B/de active Pending
- 1964-10-23 BR BR163683/64A patent/BR6463683D0/pt unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK155714B (da) * | 1978-07-04 | 1989-05-08 | Nyegaard & Co As | Fremgangsmaade til fremstilling af en steril, injicerbar, fysiologisk acceptabel oploesning af et roentgenkontrastmiddel, samt en oploesning af roentgenkontrastmidlet til brug ved fremgangsmaaden |
Also Published As
| Publication number | Publication date |
|---|---|
| FR3758M (fr) | 1965-12-13 |
| DE1234931B (de) | 1967-02-23 |
| SE303829C (sv) | 1972-04-17 |
| FI44670B (sv) | 1971-08-31 |
| IT1044727B (it) | 1980-04-21 |
| GB1069437A (en) | 1967-05-17 |
| BE654702A (sv) | 1965-02-15 |
| US3347746A (en) | 1967-10-17 |
| BR6463683D0 (pt) | 1973-07-17 |
| FI44670C (sv) | 1971-12-10 |
| AT263997B (de) | 1968-08-12 |
| DK109526C (da) | 1968-05-06 |
| NL6412391A (sv) | 1965-04-26 |
| NL152753B (nl) | 1977-04-15 |
| CH438584A (de) | 1967-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT77616B (en) | Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same | |
| CH620096A5 (sv) | ||
| KR840007393A (ko) | 포틀랜드 시멘트용 부식방지 첨가제 조성물 | |
| SE303829B (sv) | Injicerbar röntgenkontrastmedelskomposition | |
| DE19875047I1 (de) | N n- (3,5-Diacetamido-2,4,6-triiodbenzoyl)-aminoacyl-n-methylglucamide Verfahren zu deren Herstellung und diese Verbindungen enthaltende Roentgenkontrastmittel | |
| ES8506838A1 (es) | Procedimiento para la preparacion de composiciones acuosas de acido polimaleico, tensoactivos y complejadores | |
| ATE37533T1 (de) | Derivate der 4-phenyl-4-oxo-buten-2-saeure, verfahren zu ihrer herstellung, medikamente und mischungen mit diesen derivaten. | |
| GB1023495A (en) | X-ray contrast media | |
| YU311580A (en) | Process for obtaining 5-substituted derivatives of 2,4,6-triiodo-3-carbamoyl benzoic acid | |
| US2758049A (en) | Iodine dissolved in an aqueous solution of polyacrylic acid | |
| JPS55149369A (en) | Wetting agent composition | |
| GB535021A (en) | Improvements in and relating to photographic developers | |
| US2378248A (en) | Photographic art | |
| GB867880A (en) | N-acyl derivatives of (3:5-diamino-2:4:6-triiodobenzoyl)-amino acids and x-ray contrast media containing the same | |
| GB1012585A (en) | New compositions for use in acne and like conditions | |
| GB933462A (en) | Improvements in or relating to the treatment of meat | |
| GB797237A (en) | Composition for reducing period of anesthesia | |
| GB805524A (en) | Improvements in or relating to local anesthetic compositions | |
| AT269316B (de) | Hochleistungs-Reinigungsmittel und Grundstoffansatz hiefür | |
| GB470530A (en) | Improvements in and relating to the preparation of iron-tanned leather | |
| GB760620A (en) | Improvements in and relating to disinfectants | |
| GB962955A (en) | Germicidal solutions containing iodine | |
| GB474518A (en) | Improvements in or relating to cleansing agents | |
| GB793558A (en) | Improvements in or relating to tetracycline preparations | |
| GB861859A (en) | A process for the treatment of the surfaces of fabricated solid materials |